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Sixty-three patients (32 women, 31 men), chronically treated with carbamazepine, phenytoin, valproate and/or phenobarbital,
were investigated. Mean age at manifestation of epilepsy was 16.4 years; mean age at onset of documentation of seizure
frequency was 33.7 years; mean duration of follow-up was 104.8 months; mean number of documented seizures per patient
was 313.2. A statistical analysis of seizure diaries was performed. For each day the entries were the number of seizures per
day. Linear trends, the amount of variance of the seizure frequency compared to randomly distributed events, were computed
with the resulting coefficients fitting a general linear regression model. Non-random aggregations (clusters) were searched for
as well as gaps of seizure manifestation. A similar number of patients exhibited a decrease (30%) or increase (29%) of seizure
frequency during the course of epilepsy. The variance of the daily seizure frequency was in most patients (78%) significantly
higher or lower (5%) than corresponding random distributions. The coupling coefficient to the day before was significantly
larger than zero (indicating seizure clustering) in 57% of patients. Significant rhythmic components in seizure profiles (quasi-
weekly or quasi-monthly) were found in 31 patients (both male and female). Periods of increased seizure frequency (clusters)
manifested in 62% of patients; seizure gaps of at least 1 year occurred in 29 patients followed by seizure relapses in 20 patients.
In conclusion, there is no evidence for a unique type of course in chronic focal epilepsy in patients on antiepileptic drugs.
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INTRODUCTION
Anticonvulsant treatment of epilepsy with focal and/or
secondarily generalized tonic–clonic seizures (focal
epilepsy) will result in complete seizure control in
about 60–70% of patients1–3. Aetiology of epilepsy in
such patients as well as the cortical region of seizure
onset varies widely. With respect to morphological
findings, treatment outcome proved to be less success-
ful in patients with hippocampal sclerosis4.
Various studies have addressed the treatment prog-
nosis in early focal epilepsy3, 5. There have also been
many studies on the impact of add-on therapy with
new antiepileptic drugs (AEDs) in the treatment of
patients with chronic focal epilepsy. From an analy-
sis of the latter studies, Walker and Sander6 concluded
that complete seizure control is not (usually) achieved
by the use of newly developed AEDs. Consequently,
chronic focal epilepsy is not uncommon. However,
data on the temporal variation of seizure manifesta-
tion in such patients are reported only rarely7. Some
authors have examined the possible circamenstrual
rhythm of seizure manifestation in such (female)
patients7, 8 or the change of semiology of seizures dur-
ing the course of epilepsy9.
To describe the course of chronic focal epilepsy re-
sistant to treatment with AEDs we analysed the data
of patients who had continuously documented their
seizures on seizure charts. All the patients have been
treated as outpatients at the Department of Epileptol-
ogy, University of Bonn. At this department, docu-
mentation of seizures has always been an important
tool in evaluating the outcome of therapy. Based on
seizure documentation, a protocol for the analysis
of seizure frequency has been published10. Further-
more, measurement of serum levels of AEDs was
available for control of efficacy of treatment in the
patients reported here11–13. Treatment strategy was
with AED monotherapy if possible, otherwise comed-
ication with two or three AEDs was established14. The
commonly used AEDs were carbamazepine (CBZ),
valproate (VPA), phenytoin (PHE) and phenobarbital
(PB). Newly developed drugs were not available at the
time of documentation of seizures.
1059–1311/01/040239 + 08 $35.00/0 c© 2001 BEA Trading Ltd
240 J. Bauer and W. Burr
Table 1: Demographic and documentation data. Numbers
indicate total number (with respect to gender), mean and
standard deviation (in brackets).
Number of female/male patients 32/31
Mean age at manifestation of epilepsy (years) 16.4 (13.0)
Mean age at begin of documentation (years) 33.7 (13.8)
Mean duration of documentation (months) 104.8 (42.6)
Average number of documented seizures 313.2 (480)
Average number of seizures per month 3.0 (4.2)
PATIENTS AND METHODS
We analysed the seizure manifestation in 63 patients
(32 women, 31 men), who had continuously docu-
mented their seizures in seizure diaries in the 1970s
and 1980s. All patients suffered from cryptogenic
or remote symptomatic epilepsy with simple partial,
complex partial and/or secondarily generalized tonic–
clonic seizures which proved to be resistant to AED
treatment. All patients continuously received AEDs
(CBZ, VPA, PHE and/or PB) as monotherapy or in
combination. Further data on epilepsy and seizure
documentation are summarized in Table 1.
Statistical analysis
Statistical analyses were based on the seizure diaries
of the 63 patients. In these diaries, for each day (mini-
mum 1350, maximum 6930) the entries were the num-
ber of seizures per day. Time series analysis was ap-
plied on seizure density functions S(t) (‘seizure pro-
files’) with days as the units on the x-axis and seizure
count on the y-axis. In order to find out whether these
seizure profiles contain patterns, regular structures or
other qualities deviating from random distributions,
we applied several (preferably intuitive, simple and
easily interpretable) statistical approaches.
Descriptive statistics
(1) The assumption of a linear relation between
time of observation and seizure frequency was
tested by means of Pearson’s regression analy-
sis.
(2) The total variance in the individual seizure pro-
files was compared to randomly produced distri-
butions of the same number of events occurring
over the same observation period.
(3) The distribution of inter-seizure intervals was
tested for significant deviations from Poisson
distributions of given length and mean λ, fol-
lowing step 5 in Taubøll et al.7 or Milton et al.15
Generalized linear model
Following the study of Balish et al.16 we applied—
with certain modifications—the quasi-likelihood re-
gression model on the individual seizure profiles17–19.
This regression technique can be used to model the
seizure density profile as a function of any number of
independent variables. The dependent variable is usu-
ally regarded as expressing the probability of seizure
manifestation. Due to the fact that combined partial
probabilities tend to be multiplicative, modelling is
most often applied on the logarithmic function, thus
transforming the product into a sum, e.g.:
log E{S(t)} = c0+c1t+c2S(t−1)+c3S(t−2)+· · · .
A crucial problem arises when the logarithmic model
is applied on seizure profiles S(t) containing observa-
tion values of zero (which is the normal case with rare
events) because calculation of the goodness of fit re-
quires the logarithm of zero which is, of course, not
defined. Balish et al.16 have not discussed in detail
how to overcome this problem, but obviously they did.
(For instance, most of the observed seizure count data
of their patient No 6 is zero and, correspondingly, c0
is negative.) Zeger and Quagish9 made the proposal to
replace S(t) by max[S(t), c] with 0< c< 1; in other
words, to introduce a non-zero offset c. As the value
of c was not further discussed, a natural definition does
not seem to exist. For dichotomous data (e.g. when
analysing the original profiles with an x-resolution of
days and y-values of 0 for no seizure and of 1 for
seizure manifestation) the use of an offset is equiva-
lent to the transformation:
0→−a, 1→ 0 (i.e.:− a = log(c));
for c = 0.5 this yields:
0→−0.69315, 1→ 0,
for c = 0.1 we obtain:
0→−2.3025, 1→ 0.
As a mild modification we decided to replace S(t) by
S(t)+ c with c > 0, resulting in the transformation:
0→ log(c), 1→ log(1+ c);
for c = 1 this yields:
0→ 0, 1→ log(2) = 0.69315,
for c = 0.1 the result would be:
0→−2.3025, 1→ log(1.1) = 0.09531.
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With binary data these approaches are almost equiva-
lent, differing only by scaling factors.
The quasi-likelihood regression model for each
patient was calculated using the software SVDFIT of
the Numerical Recipes, in a modified form20. A step-
wise augmented number of parameters was applied.
Testing the significance of the solution was done in
the following way: for each profile a set of 1000 ran-
domly produced temporal distributions with identical
length and total number of events was also submit-
ted to the quasi-likelihood model. The resulting set
of variance values of reduction (vr) were then com-
pared to the most simple model assumption (including
only c0, i.e. the deviation from the mean value). From
this comparison, confidence levels of the underlying
vr -distribution were defined and then used as the con-
fidence limits. Against these confidence limits each
vr -value of the actual seizure profiles was compared.
When exceeding the 2% level of the distribution orig-
inating from random profiles, results of the modelling
were regarded to be statistically significant.
The parameter c1 represents the part of a time trend
in the model, c2 and c3 the contribution of the his-
tory (in the sense of an auto-regressive model), i.e.
the seizure at a given time depending on the number
of seizures during the past time unit. This latter part
could have been extended to any desired higher order
model with S(t−k) accounting for the patient’s seizure
history.
Estimation of rhythmic components
In contrast to the study of Balish et al.16, the gen-
eral model we have applied here did not include ex-
plicit parameters accounting for a cyclic behaviour
(c4 cos(2piωt + ϕ)). The reason is that in the general
model the variation of the amplitude (c4) alone (as-
suming both the parameters of frequency ω and phase
ϕ are fixed) would be an oversimplification. However,
when ω and ϕ are treated as independent variables,
the numerical problems increase tremendously and at
the same time the threshold for statistical significance
would have to be enlarged.
In order to overcome this difficulty, while still ob-
taining estimates of rhythmic parts within the seizure
profiles, conventional power spectral estimation algo-
rithms were applied in a separate step on the residuals
after having applied linear regression approximation.
Again, statistical significance of spectral peaks (which
were only accepted when still apparent even after per-
forming a 3-point smoothing over the power spectral
components) was tested by comparison to the 1% lev-
els of the corresponding distribution originating from
random profiles submitted to the identical power spec-
trum estimation procedure. Subroutine SPCTRM was
used including Parzen window, half segment overlap,
and the Fourier transform subroutine FOUR1 of the
Numerical Recipes20.
Seizure clusters
With this approach we intended to use an additional,
and likewise intuitive, way of analysing seizure pro-
files with regard to deviations from random time
courses. These deviations may not only exist in cer-
tain structures which can be modelled as described
in the previous section. They may also be character-
ized by the existence of temporal clusters of extraor-
dinary high seizure incidence. In this part of the anal-
ysis we were looking for ‘seizure clusters’ defined as
those time periods during which seizure occurrence is
significantly increased compared to the rate expected
from the individual mean. As the data base of this step
we used the compressed profiles, i.e. months, as time
units. Again, the analysis was based on the assump-
tion that seizure occurrence follows that of Poisson-
distributed profiles. All possible temporal subsections
(with lengths of up to one half of the total diary length)
were tested whether or not their content of actually
registered seizures was significantly higher than ex-
pected from a random distribution.
As the significance level we used the 1% confidence
limit of corresponding Poisson distributions. Time pe-
riods for which the lower level of the confidence in-
terval of the actual seizure number exceeded the upper
level of the confidence interval expected for Poisson
profiles with the same length and λ, were defined as
clusters.
Seizure-free intervals
The search for seizure free intervals was restricted to
gaps of a minimum of 1 year. We distinguished be-
tween those seizure-free periods which are followed
by relapse and those profiles that remain seizure free
until the end of the documentation.
RESULTS
Samples of seizure profiles have been plotted in Fig. 1
and 2. The results for the total patient group have
been compiled in Table 2. Linear regression analy-
sis illustrated that approximately the same number of
patients show decreasing and increasing trends (30%
and 29%, respectively) while in 41% there was no
significant trend. The variance of the daily seizure
frequency was in most patients (78%) significantly
higher, in 5% lower and 17% not significantly differ-
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ent from corresponding random distributions. In only
one patient (1.5%) did the histogram of inter-seizure
intervals deviate significantly from the characteristic
(logarithmic) Poisson behaviour.
When fitting a quasi-likelihood regression model or
General Linear Model (including four terms) the re-
sults concerning the trend (c1) are identical (as to be
expected) to that of the simple linear regression anal-
ysis. The term c2 (regression coefficient to the day
before in history) was significantly larger than zero
(indicating clustering) in 57% of the cases; in a few
patients (6%) the c2 coefficients were found to be neg-
ative (indicating that a high seizure frequency low-
ers the expected number of seizures on the following
day); in 36% no significant dependence on the previ-
ous day was found. Regarding regression of seizure
probability with a delay of 2 days the percentage of
non-significant cases was higher (63%), while positive
and negative dependence was nearly in balance.
Significant rhythmic components in the seizure pro-
files (comparing the Fourier components after trend re-
moving) were found in 31 cases (approximately 50%).
On seven occasions the periods were quasi-weekly (6–
8 days) and on 13 occasions they were quasi-monthly
(25–35 days). The distribution according to gender
was non-significant (eight women, five men).
The search for periods with significantly higher
seizure incidence than expected from corresponding
randomly distributed seizures yielded clusters in 62%
of the patients. Gaps in seizure manifestation for more
than 1 year were documented in 29 patients (46%), of
which in 20 patients the gap was followed by relapse
of seizures.
Inter-variable comparisons
A few comparisons between the variables seem worth-
while mentioning:
With regard to gender there was no significant dif-
ference between patients with or without seizure clus-
tering: The cluster group contained 20 women (56%)
and 16 men (44%), the non-cluster group 12 women
(46%) and 14 men (54%). The patients’ age at the time
of the first seizure was significantly (P< 0.02) lower
in the cluster group (1–32 years; mean 12.4 years)
than in the non-cluster group (5–57 years; mean
21.7 years).
Duration of seizure documentation was almost
identical with 48–209 months (mean 111.4 months)
in the cluster group and 45–228 months (means
97.5 months) in the non-cluster group.
Clusters and trends (no matter whether positive or
negative) were significantly related to each other: in
26 patients (41.1%) both clusters and trends were ex-
isting, 16 profiles (25.4%) consistently demonstrated
neither clusters nor any significant trend; in 21 cases
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Fig. 1: Samples of seizure profiles in four patients. For better
illustration, the units on the abscissa are months instead of
days. Figures (a) and (b) represent minimum configurations
with rare seizures over several years. In (a) seizures have
stopped for the last 42 months for observation while in patient
(b), after several pauses (up to 24 months), at the end of doc-
umentation there is a striking increase of seizure frequency.
Figures (c) and (d) are examples for higher mean seizure
rates (5.5 or 9.1, seizures per month, respectively). Figure
(c) shows an almost equally distributed and unstructured pro-
file and (d) represents a significantly increasing course, with
only short gaps and a prominent peak lasting more than
12 months.
(33.3%) both qualities were not congruent. In the last
24 months of documentation 9/63 patients (14.3%) re-
mained seizure free. Six of these patients had had clus-
ters in the previous course of their disease.
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Fig. 2: Example for statistical analysis of the course of epilepsy in a patient. This figure takes up case (d) of Fig. 1 together with
the result of linear regression analysis (solid line). Although statistically significant (in the sense that the null hypothesis can be
rejected), a linear fit is far from being good. The increase is mainly due to the period of high seizure incidence (‘cluster’) at the
beginning of the second half of the profile. The high value of the variance also reflects the non-stationary nature of the seizure
profile; in this case it exceeds the 99% region calculated on the basis of an identical number of events randomly distributed over
the same interval.
Table 2: Results of statistical analysis. Neg. = negative; pos. = positive; no dev. = no deviation; n.s. = not significant; history =
statistical analysis of the relationship between seizure occurrence on a particular day in relation to seizure occurrence on the day
before (t − 1) or 2 days before (t − 2), for details see the Patients and Methods section.
Trend over time (linear regression) neg. 19 pos. 18 n.s. 26
Variance outside 90% quantile lower 3 higher 49 within 11
Inter-seizure intervals yes 1 no dev. 62
(deviation from Poisson distributions)
Linear Model: (significant coefficients)
trend (∗t) neg. 18 pos. 17 n.s. 28
history (∗ p(t − 1)) neg. 4 pos. 36 n.s. 23
history (∗ p(t − 2)) neg. 12 pos. 11 n.s. 40
Rhythms(significant in power spectrum) yes 31 no 32
weekly (6–8 days) 7
monthly (25–35 days) 13
Clusters of high seizure incidence yes 36 no 27
Gaps > 1 year followed by relapse yes 20 no 43
Gaps > 1 year at end of documentation yes 9 no 54
DISCUSSION
The analysis of seizure frequency in the reported
patients does not reflect the natural course of epilepsy.
All patients were on AEDs and suffered from chronic
focal epilepsy. To characterize such patients the effect
of anticonvulsant treatment and the natural course of
focal epilepsy has to be taken into consideration.
Hospital-based studies of newly diagnosed epilepsy
have demonstrated that 20–30% of patients do not
enter remission1–3. Shinnar and Berg21 discussed the
extent to which anticonvulsant drugs, in suppressing
seizures, might improve the prognosis of seizures and
epilepsy by altering the underlying natural history of
epilepsy. The clinical data indicate that anticonvul-
sant drug treatment, although effective in suppressing
seizures, is not effective in altering the long-term prog-
nosis for seizure remission.
There is some evidence that the prognosis of
epilepsy with focal seizures becomes established soon
after its presentation. In patients with seizures becom-
ing intractable in the early phase of the disease an ac-
celerating seizure rate was found, with the time be-
tween seizures progressively shortening. This led to
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the suggestion that there was an accelerating disease
process in the early stages22. In the Kent population-
based study, patients could be divided up into burst,
intermittent, continuous and single seizures2, 23. Those
patients who had a continuous pattern from the start of
treatment were more likely to remain with the unremit-
ting seizures, often unresponsive to treatment24, 25.
Zielinski26 reported on ‘epileptics not in treatment’,
analysing patients not regularly attending a physician.
Patients who are not going to be treated probably often
suffer from epilepsy with a benign course. In the study
by Zielinski26 33% of such patients became seizure
free for at least 5 years without being treated with
AEDs. Nowadays, there is evidence that 50% of peo-
ple with completely untreated epilepsy eventually go
into remission5, 27. The prevalence of epilepsy in coun-
tries with a low number of treated patients (Ecuador,
Nigeria, Ethiopia) is about the same as in Europe or
North America5, 28, 29. However, only 20% of patients
with chronic epilepsy have seizure-free periods and
even short-term remission is unlikely in the majority
of these patients30, 31.
The conclusions from the analysis of data presented
here have to be restricted to a population of patients
with focal epilepsy resistant to AED treatment with-
out spontaneous remission.
Analysis of seizure frequency in the reported
patients is under the assumption that non-compliance
generally did not contribute to the manifestation of
seizures. The measurement of AED serum levels dur-
ing follow-up helped to prove non-compliance in the
reported patients. However, compliance is difficult to
detect and to control32 and in some patients non-
compliance might have occasionally contributed to
seizure frequency.
During the course of epilepsy periods of higher or
lower seizure frequency can be observed. Seizure clus-
tering was observed in 36/63 patients (57.1%) in our
study and has been described by other investigators7.
Seizure clustering was reported to be more common
in epileptic outpatients (i.e. in patients with a more be-
nign course of their disease) than in inpatients33. How-
ever, seizure clustering was also mentioned as an indi-
cator of a lower probability of remission21, 22.
Apart from clusters, oscillating or periodic pat-
terns of seizure occurrence have been observed in
patients with focal epilepsy. This was the case in 31/63
of patients (49.2%) in our study. Other authors re-
ported on the prevalence of periodic patterns in 0%15,
30%16, 33, 32%34 and 50%7 of patients. The variation
probably reflects a problem of definition of period-
icity; circamenstrual rhythms have been described as
well as circadian and circavigintan rhythms (yearly or
seasonal seizure increases35–38).
At present there is no general explanation for the
phenomenon of seizure clustering or periodic patterns
of seizure occurrence. In some female patients the
variation of sex steroid hormones (exerting convul-
sant or anticonvulsant effects) might contribute to a
circamenstrual rhythm of (increased) seizure mani-
festation8. However, in only some of the patients re-
ported here did the cluster interval show a circamen-
strual rhythmicity. Furthermore, this was observed
in female (eight patients) as well as in male (five
patients) patients. This finding is in accordance with
results published by Almquist34, who demonstrated
that seizure rhythmicity is nearly as common in male
(29%) as in female (35%) patients. The possible effect
of suspected exogenous trigger factors, such as lunatic
or seasonal phases, are not well understood and could
not be detected in some studies7.
AEDs might also contribute to a periodic variation
of seizure occurrence or to seizure clustering. Based
on 2227 examinations in 272 epileptic patients, Rajna
and Veres39 investigated the relation between seizure
frequency and life events of negative or positive emo-
tional nature. Negative life events went with a dete-
rioration, positive factors with a decrease of seizure
frequency in most cases. Results of AED serum lev-
els suggest that emotional factors exert their effect on
seizure occurrence by influencing the patient’s compli-
ance39, 40. Helmchen et al.41 reported that AEDs re-
duced the mean frequency of seizures, but increased
their regularity, thereby revealing a rhythmic compo-
nent. Other authors suggested that in some patients
during the course of epilepsy endogenous or ex-
ogenous factors contribute to the manifestation of
seizures. Griffith and Fox42, however, demonstrated
that seizure patterns became irregular and distorted af-
ter the introduction of drugs.
We analysed the data with respect to a linear regres-
sion in the time course. One might wonder whether
patients chronically treated with AEDs will experi-
ence a general decrease of seizure frequency. In the
present group of patients examined, a significant trend
in seizure frequency was detected in 37/63 patients
(58.7%). However, half of these patients actually had
an increase, the other half a decrease of seizures. In
conclusion, trends in seizure frequency may occur in
a considerable number of patients with chronic focal
epilepsy. In a study by Balish et al.16, 6/13 patients
(46.1%) had a significant linear time trend (with de-
creasing seizure frequency in two patients and increas-
ing seizure frequency in four patients).
There is common evidence that the manifestation of
seizures in a certain time period might trigger the re-
lapse of further seizures. Of 18 patients investigated
by Taubøll et al.7, only two patients did not display
stationary distribution of seizures, a finding in accor-
dance with results of other investigators15, 33. Seizure
diaries presenting a stationary process were analysed
with respect to randomness in seizure distribution.
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Eleven of the 16 seizure diaries studied, representing
10 out of 14 patients, were non-Poisson distributed. A
non-Poisson distribution was found by Binnie et al.33
in 15/30 (50%) and by Milton et al.15 in 10/22 (45%)
patients. Taking together, the 66 patients from the
above-mentioned studies were analysed, 35 of which
(53%) showed a non-Poisson distribution of seizures,
indicating that in more than half the patients epilep-
tic seizures do not occur randomly. As an explana-
tion, an epileptic seizure might itself, through sec-
ondary mechanisms, influence the possibility of hav-
ing a new seizure within a short period of time, thereby
creating a dependency between the attacks. Taubøll
et al.7 found dependencies between ictal events in
8/15 (53%) of the stationary diaries, representing
8/15 patients. Binnie et al.33, however, were not able
to establish a correlation between successive inter-
seizure intervals when studying the serial correlation
coefficients of intervals at various lag times.
We investigated the deviation from randomly dis-
tributed daily seizure occurrence by testing the vari-
ance. In the majority (49/63 = 77.7%) of patients
the variance exceeded the 90% quantile estimated
for the corresponding random distribution, in three
patients the variance was significantly lower, in 17%
(11 patients) the variance was within the expected lim-
its. One explanation of this finding may be a trend in
seizure frequency, however, clustering may also con-
tribute to this result. In conclusion, temporal distribu-
tion of seizure frequency varies in a considerable num-
ber of such patients. This might be a consequence of
the AED therapy or the epileptic process itself.
As a further approach to describe the peculiarities
of the time course of seizure manifestations we inves-
tigated the distribution of the inter-seizure intervals.
This was done by fitting a linear regression line to the
log-plot of the integrated number of intervals larger
than the ordinate. In only one patient did we observe
a deviation from the Poisson distribution which was
statistically significant. Compared to previous studies,
this finding is partly in agreement15, partly in contra-
diction7, 33, 43, 44. One explanation might be that our
analysis used a larger scale (with units of seizure-free
days in contrast to the intervals between EEG dis-
charges); the extremely low rate of significant devia-
tions might also be due to the statistical level of sig-
nificance we requested.
There is no evidence for a unique or even major
type of course in chronic focal epilepsy with patients
on AED treatment. Instead, in the investigated un-
selected group, unstructured chronological behaviour
coexists with pronounced trends (increasing and de-
creasing), rhythmic structures (not related to gen-
der), and history-dependent courses (microscopic sign
for clustering behaviour). Clear cut deviations from
the log-linear behaviour of inter-seizure interval his-
tograms (as would be expected for the assumption of
a Poisson distribution) was very infrequent. Macro-
scopic periods of high seizure frequency, and of long
seizure-free intervals with and without subsequent re-
lapse were found within the expected limits.
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